Understanding Childhood Cancer With Dr Geoff
The MEK inhibitors: trametinib and selumetinib
February 18, 2021
The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis. Link to Patreon See acast.com/privacy for privacy and opt-out information.
Understanding Childhood Cancer with Dr Geoff.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast